Ketamine Withdrawn Phase 0 Trials for Depression / Malignant Neoplasm of Pancreas / Head and Neck Carcinoma Prevention

IndicationsStatusPurposePhase
WithdrawnPrevention0
clinicaltrials.gov IdentifierTitleDrugs
NCT02442739Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers